Skip to content

The Effect of a Post-operative Exercise Programme Versus Standard Care on Physical Fitness of Patients With Breast Cancer Undergoing Deep Inferior Epigastric Perforator (DIEP) Flap Reconstruction Surgery

The Effect of a Post-operative Exercise Programme Versus Standard Care on Physical Fitness of Patients With Breast Cancer Undergoing Deep Inferior Epigastric Perforator (DIEP) Flap Reconstruction Surgery

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07672392
Acronym
EXERCISE DIEP
Enrollment
78
Registered
2026-06-26
Start date
2024-08-01
Completion date
2028-12-30
Last updated
2026-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer, Exercise

Keywords

Breast cancer, DIEP Reconstruction, Exercise

Brief summary

All patients undergoing mastectomy for breast cancer should be offered the option of reconstructive surgery. The Deep Inferior Epigastric Perforator Flap or DIEP reconstruction as it is commonly referred to, is becoming the favoured reconstruction by both patients and surgeons as it gives a great cosmetic outcome as well as being a good option for patients who may have to undergo radiotherapy treatment after their surgery. Exercise has been demonstrated in previous research to improve tolerance of treatment (particularly chemotherapy), post operative fatigue and the overall quality of life in patients undergoing cancer treatment. Furthermore, it has shown to improve survival in patients who are being treated for breast cancer. The investigators are undertaking this study to investigate whether a structured exercise programme will improve patients fitness after surgery and ultimately improve their recovery after their reconstructive surgery. To do this, half of the people taking part will be undertaking a structured exercise programme and the other half will not and will be assessing which group recover better after their surgery. Currently, no breast reconstruction patients in Ireland are receiving a formal "exercise prescription" after their surgery so will be looking to see if this helps people recover better before it is made standard care for every breast patient in Ireland.

Detailed description

Primary Objective: To evaluate the impact of a structured, post-operative exercise programme on patient-reported and functional outcomes following DIEP flap breast reconstruction. Secondary Objectives: * To examine the effects of the exercise programme on upper and lower limb strength, body composition (BMI, fat and muscle mass, bone density), and functional recovery. * To evaluate the influence of exercise on post-operative complication rates, length of hospital stay and time to return to daily activities. * To explore changes in psychological health and body image perception using validated questionnaires. * To assess adherence, feasibility, and safety of the structured exercise programme within a breast reconstruction population. * To perform an exploratory health-economic analysis comparing the costs and potential healthcare savings associated with the intervention versus standard care.

Interventions

BEHAVIORALStructured individualised 12-week post operative exercise programme

Structured individualised 12-week post operative exercise programme based on ACSM oncology guidelines, incorporating aerobic, resistance and flexibility training delivered in person or via zoom.

Sponsors

Royal College of Surgeons, Ireland
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Intervention model description

This is a randomised control trial that seeks to evaluate the impact of a structured, post-operative exercise programme on patient-reported and functional outcomes following DIEP flap breast reconstruction.

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Women aged 18 years and older 2. Candidates who have already been selected to undergo mastectomy and reconstruction by the breast MDT for the following indications: 1. Genetic mutation carriers undergoing risk-reducing mastectomy. 2. Ductal carcinoma in situ (DCIS) requiring mastectomy. 3. Early invasive breast cancer requiring mastectomy. 4. The tumour must not have skin involvement and no evidence of invasive disease within 1cm of skin, nipple or pectoralis major muscle (as proven on MRI). 3. Candidates for breast reconstruction with DIEP. 4. Fluent in English 5. Fit for general anaesthetic Signed informed consent form

Exclusion criteria

1. Advanced breast cancer with skin involvement. 2. Undergoing bilateral DIEP reconstruction or other forms of breast reconstruction (e.g., TRAM, implant-based, LD flap). 3. Pregnancy 4. Lactation Patients with insufficient English to sign an informed consent (i.e. interpreter required).

Design outcomes

Primary

MeasureTime frameDescription
Cardiorespiratory FitnessMeasured at baseline (recruitment), 6 months postoperatively and at 1 year postoperativelyCardiorespiratory fitness measured using the 6-Minute Walk Test (6MWT). Outcome reported as change in distance walked (metres) from baseline to 6 months post-operatively. Greater distance indicates improved cardiorespiratory fitness.

Secondary

MeasureTime frameDescription
Hand Grip Strength6 months and 12 months post operativelyMeasured using a hand dynamometer and reported in kilograms.
Body Mass IndexAt six months and 12 months postoperativelyBody mass index (BMI) calculated from measured weight and height and reported in kilograms per square meter (kg/m²).
EQ5D5L Health Related Quality of LifeAt 6 months and 12 months post operativelyQuality of Life and Psychosocial Health: Assessed using the BREAST-Q (psychosocial and sexual well-being domains)
Percentage Body FatAt 6 months and 12 months postoperativelyPercentage body fat measured using bioelectrical impedance analysis with a Tanita device and reported as percentage body fat (%).
Muscle MassAt 6 months and 12 months postoperativelyMuscle mass measured using bioelectrical impedance analysis with a Tanita device and reported in kilograms (kg).
Bone MassAt 6 months and 12 months postoperativelyBone mass measured using bioelectrical impedance analysis with a Tanita device and reported in kilograms (kg).
Lower Limb StrengthMeasured at 6 months and 1 year postoperatively.Measured using the 30 second Sit to Stand Test

Countries

Ireland

Contacts

CONTACTArnold Hill, MB, BCh, BAO, MCh, FRCSI
adkhill@rcsi.com+35318093000
CONTACTAisling Hegarty, PhD
Aislinghegarty@rcsi.ie018093000

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 27, 2026